Skip to main content

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 2, Number 4, 1 December 2001

Book Reviews

Editorial
pp. i-ii(2)
Authors: Grillo-Lopez, A.J.; McClure, A.; Dallaire, B.K.

Favourites:
ADD

Reviews

Non-Hodgkin's Lymphoma: Review of Conventional Treatments
pp. 279-291(13)
Authors: Multani, P.; White, C.A.; Grillo-Lopez, A.

Favourites:
ADD

Monoclonal Antibodies: A New Era in the Treatment of Non-Hodgkin's Lymphoma
pp. 301-311(11)
Authors: Grillo-Lopez, A.J.; Dallaire, B.K.; McClure, A.; Weaver, R.; Varns, C.; Wei, A.; Allen, R.; Lee, D.; Shen, D.; Leonard, J.; Multani, P.; White, C.A.

Favourites:
ADD

Toxin-Labeled Monoclonal Antibodies
pp. 313-325(13)
Author: Kreitman, R.J.

Favourites:
ADD

Radioimmunotherapy of B-Cell NHL
pp. 327-339(13)
Authors: Meredith, R.F.; Knox, S.J.

Favourites:
ADD
Favourites:
ADD

Antibody Therapy of Acute and Chronic Leukemias
pp. 357-367(11)
Authors: Cataland, S.R.; Lucas, M.; Byrd, J.C.

Favourites:
ADD

Future Approaches for Treating Hematologic Disease
pp. 369-382(14)
Authors: Reff, M.; Braslawsky, G.; Hanna, N.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more